0001396677-17-000034.txt : 20170824
0001396677-17-000034.hdr.sgml : 20170824
20170824194244
ACCESSION NUMBER: 0001396677-17-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170823
FILED AS OF DATE: 20170824
DATE AS OF CHANGE: 20170824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seelos Andrew W
CENTRAL INDEX KEY: 0001396677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23731
FILM NUMBER: 171050261
MAIL ADDRESS:
STREET 1: C/O NUTRACEUTICAL CORPORATION
STREET 2: 1400 KEARNS BOULEVARD, 2ND FLOOR
CITY: PARK CITY
STATE: X1
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0001050007
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 870515089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
BUSINESS PHONE: 4356556000
MAIL ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-08-23
1
0001050007
NUTRACEUTICAL INTERNATIONAL CORP
NUTR
0001396677
Seelos Andrew W
C/O NUTRACEUTICAL CORPORATION
1400 KEARNS BOULEVARD, 2ND FLOOR
PARK CITY
X1
84060
UNITED STATES
0
1
0
0
VP, Finance and Treasurer
Common Stock
2017-08-09
5
G
0
E
1700
0
D
20814.893
D
Common Stock
2017-08-23
4
D
0
20814.893
D
0
D
Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 21, 2017, by and among Nutraceutical International Corporation (the "Company"), Nutrition Parent, LLC ("Parent") and Nutrition Sub, Inc. ("Merger Sub"), at the effective time of the merger (the "Effective Time") of Merger Sub with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent, each share of the Company's common stock, par value $0.01 per share (the "Common Stock"), owned by the reporting person was converted into the right to receive $41.80 in cash without interest (the "Merger Consideration").
/s/ Alison Pitt, attorney in fact
2017-08-24